Facebook
X
LinkedIn
Forward2026 Science of Skin Summit
September 17, 2026 to September 20, 2026
Research surrounding skincare and aesthetic medicine is evolving quickly, leading to continual advancements in products and treatment approaches. In addition, dermatologic conditions such as hidradenitis suppurativa, alopecia areata, chronic spontaneous urticaria, pruritus, atopic dermatitis, acne, vitiligo, skin cancer, non-melanoma skin cancer (NMSC), melanoma, and rosacea can significantly impact patients’ quality of life, affecting their physical, emotional, social, and economic well-being. To provide optimal patient care, the dermatology community continues to pursue innovative therapies and evidence-based strategies aimed at improving outcomes and quality of life for individuals living with these conditions. Therefore, ongoing educational opportunities are critical to keeping dermatologists and other healthcare professionals informed of the latest clinical developments and treatment advances.
The skincare industry continues to grow rapidly, with consumers increasingly turning to over-the-counter (OTC) products to improve both the appearance and health of their skin. As a result, it is essential for medical practitioners to remain informed about the scientific evidence, efficacy, and safety of these products in order to effectively educate and guide their patients.
The Science of Skin Summit is designed to provide comprehensive education on practice management, skincare ingredients, AI in dermatology, longevity, hair nutraceuticals and supplements, and topical therapeutics for common skin conditions. The program will also explore the science behind a wide range of dermatologic procedures and treatment options. In addition, attendees will receive updates on the diagnosis and management of conditions including alopecia areata, hidradenitis suppurativa, chronic spontaneous urticaria, pruritus, atopic dermatitis, acne, psoriasis, skin cancer, NMSC, melanoma, actinic keratosis, and rosacea. Educational content will be delivered through a variety of proven learning formats, including expert panel discussions and didactic lectures.
Target Audience
This activity is designed for an audience of nurses, physicians, and physician associate.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Review current treatment options for patients with alopecia areata and scarring alopecia.
- Review the evolving landscape of non-steroidal therapies in dermatology, including topical agents, targeted oral therapies, and biologics, and discuss their role in the treatment of inflammatory, autoimmune, and chronic skin conditions.
- Compare new and emerging therapies for Atopic Dermatitis (AD)
- Review current evidence and updated guidelines to select and individualize safe and effective acne vulgaris treatment strategies, including new and emerging therapies.
- Describe the current and emerging applications of artificial intelligence and machine learning in dermatology clinical practice.
- Review treatment strategies, based on knowledge of the indications, efficacy, and risks of available rosacea therapies, to achieve therapeutic goals in rosacea treatment.
- Describe advances in the management of patients with Chronic spontaneous urticaria.
- Review the prevalence, severity, and impact of hidradenitis suppurativa (HS).
- Discuss advances in treatment of melanoma and non-melanoma skin carcinomas.
- Review new and emerging treatments for non-melanoma and melanoma skin cancers.
- Describe the biologic processes associated with aging and longevity in dermatology.
- Review current and emerging approaches related to longevity and regenerative dermatology.
- Discuss the current and emerging therapies available to manage moderate to severe psoriasis.
- Review the latest advanced techniques in lasers, light, ultrasound, and radiofrequency devices.
- Review treatment options for patients with hair loss.
- Describe advances in the management of patients with vitiligo.
- Describe the applications of neurotoxins, dermal fillers, surgical techniques, and minimally invasive procedures in facial rejuvenation and the treatment of submental fat.
- Discuss indications, contraindications, and properties of existing and emerging neuromodulators and dermal fillers approved for use in the US.
- Recognize the aesthetic implications of GLP-1–induced weight loss therapies and review evidence-based strategies for addressing facial volume loss and skin laxity through non-surgical interventions such as dermal fillers and energy-based skin tightening.
- Develop strategies to build and maintain a professional presence that supports career growth, visibility, and credibility in the field of dermatology.
- Review effective patient communication strategies that improve understanding, trust, and overall patient experience.
- Describe how to build a product regimen to achieve the goals for a particular patient.
- Identify evidence-based approaches for selecting and incorporating topical ingredients into individualized treatment plans for various skin conditions and aesthetic concerns.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
Austin, TX
United States
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Committee Member, Planner, Staff(s)
Patricia Farris
has a financial relationship (Advisor) with Nutraceutical Wellness ;.
has a financial relationship (Advisor) with Kenvue ;.
has a financial relationship (Advisor) with Skinceuticals ;.
has a financial relationship (Advisor) with Skinbetter ;.
has a financial relationship (Advisor) with AlumierMD ;.
has a financial relationship (Advisor) with Bubble ;.
has a financial relationship (Advisor) with Vichy;.
has a financial relationship (Advisor) with RegimenMD ;.
has a financial relationship (Advisor) with Primus ;.
has a financial relationship (Advisor) with Galderma ;.
Edward Lain, MD
has a financial relationship (Advisor) with Galderma;.
has a financial relationship (Consultant) with Galderma;.
Speaker, Instructor, Faculty(s)
Glynis Ablon, MD, FAAD
has a financial relationship (Speaker) with nutrafol;.
has a financial relationship (Researcher) with church dwight;.
has a financial relationship (Researcher) with everwell;.
has a financial relationship (Researcher) with valensa;.
Lindsay Ackerman, MD
has a financial relationship (Advisor) with Eli-Lilly;.
has a financial relationship (Advisor) with Lilly ICOS LLC;.
has a financial relationship (Advisor) with AbbVie;.
has a financial relationship (Advisor) with Bristol-Myers Squibb;.
has a financial relationship (Advisor) with Novartis;.
has a financial relationship (Advisor) with Sanofi;.
has a financial relationship (Advisor) with Timber Pharmaceuticals;.
has a financial relationship (Advisor) with Janssen Pharmaceuticals, Inc.;.
has a financial relationship (Advisor) with UCB;.
has a financial relationship (Consultant) with AbbVie;.
has a financial relationship (Consultant) with Lilly ICOS LLC;.
has a financial relationship (Speaker) with AbbVie;.
has a financial relationship (Speaker) with Amgen;.
has a financial relationship (Speaker) with arGEN-X;.
has a financial relationship (Speaker) with Bristol-Myers Squibb;.
has a financial relationship (Speaker) with Eli Lilly;.
has a financial relationship (Speaker) with Helsinn Healthcare;.
has a financial relationship (Speaker) with Kyowa Kirin;.
has a financial relationship (Speaker) with Lilly ICOS LLC;.
has a financial relationship (Speaker) with Pfizer Inc.;.
has a financial relationship (Speaker) with Sun Pharmaceutical Industries Ltd.;.
has a financial relationship (Speaker) with Galderma;.
Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, FSDNP
has a financial relationship (Advisor) with Eli Lilly;.
has a financial relationship (Advisor) with Arcutis;.
has a financial relationship (Advisor) with Incyte;.
has a financial relationship (Advisor) with Organon;.
has a financial relationship (Advisor) with Takeda;.
has a financial relationship (Advisor) with Sanofi;.
has a financial relationship (Advisor) with Regeneron;.
has a financial relationship (Advisor) with Leo Pharma;.
has a financial relationship (Advisor) with Johnson & Johnson;.
has a financial relationship (Advisor) with Galderma;.
has a financial relationship (Advisor) with UCB;.
has a financial relationship (Advisor) with Sun Pharma;.
has a financial relationship (Advisor) with Alumis;.
has a financial relationship (Advisor) with Novartis;.
has a financial relationship (Advisor) with Amgen;.
has a financial relationship (Advisor) with AbbVie;.
Hilary baldwin
has no relevant financial relationships to disclose at this time.
Ashish Bhatia, Ashish C. Bhatia, MD, FAAD, FASDS, FASMLS
has a financial relationship (Consultant) with Allergan/Abbvie;.
has a financial relationship (Consultant) with Arcutis;.
has a financial relationship (Consultant) with Avita Medical ;.
has a financial relationship (Consultant) with Bausch Health;.
has a financial relationship (Consultant) with Biacure;.
has a financial relationship (Consultant) with Biofrontera;.
has a financial relationship (Consultant) with Cutera ;.
has a financial relationship (Consultant) with Cynosure;.
has a financial relationship (Consultant) with Cytrellis ;.
has a financial relationship (Consultant) with Ecobandage;.
has a financial relationship (Consultant) with Estée Lauder;.
has a financial relationship (Consultant) with Imperious;.
has a financial relationship (Consultant) with Jeisys;.
has a financial relationship (Consultant) with LRM Aesthetics;.
has a financial relationship (Consultant) with Luminoma Diagnostics Limited;.
has a financial relationship (Consultant) with Medline;.
has a financial relationship (Consultant) with MiMedx;.
has a financial relationship (Consultant) with OurSelf/GloPharma;.
has a financial relationship (Consultant) with Pfizer;.
has a financial relationship (Consultant) with RBC Consultants;.
has a financial relationship (Consultant) with Revance;.
has a financial relationship (Consultant) with Regeneron ;.
has a financial relationship (Consultant) with Restore Biologics Holding dab Xtresse;.
has a financial relationship (Consultant) with Solta;.
has a financial relationship (Consultant) with Suasion Group LLC;.
has a financial relationship (Consultant) with Sun Pharmaceuticals ;.
has a financial relationship (Consultant) with Theravant Corp. ;.
has a financial relationship (Consultant) with UCB, Inc;.
has a financial relationship (Speaker) with Allergan;.
has a financial relationship (Speaker) with Arcutis;.
has a financial relationship (Speaker) with Cutera ;.
has a financial relationship (Speaker) with DermEd;.
has a financial relationship (Speaker) with MiMedx;.
has a financial relationship (Speaker) with Paradigm Medical;.
has a financial relationship (Speaker) with Pfizer;.
has a financial relationship (Speaker) with Revance;.
has a financial relationship (Speaker) with Theravant Corp;.
has a financial relationship (Researcher) with Abbvie;.
has a financial relationship (Researcher) with Avita Medical;.
has a financial relationship (Researcher) with Cutera;.
has a financial relationship (Researcher) with Emblation;.
has a financial relationship (Researcher) with Lilly;.
has a financial relationship (Researcher) with Medline;.
has a financial relationship (Researcher) with Novascan;.
has a financial relationship (Researcher) with R2 Technologies;.
has a financial relationship (Individual stocks and stock options) with Abbvie/Allergan;.
has a financial relationship (Individual stocks and stock options) with Bausch Health;.
has a financial relationship (Individual stocks and stock options) with Derm MD;.
has a financial relationship (Individual stocks and stock options) with Genzum;.
has a financial relationship (Individual stocks and stock options) with Impericus;.
has a financial relationship (Individual stocks and stock options) with SimSkin;.
has a financial relationship (Individual stocks and stock options) with Sonoma;.
has a financial relationship (Individual stocks and stock options) with Theravant Corp;.
has a financial relationship (Individual stocks and stock options) with Cytrellis;.
has a financial relationship (Individual stocks and stock options) with Impericus;.
has a financial relationship (Individual stocks and stock options) with Zalea;.
has a financial relationship (Executive role) with Theravant Corp.;.
has a financial relationship (Executive role) with DermEd ;.
has a financial relationship (Executive role) with OurSelf/GloPharma;.
Neal Bhatia
has no relevant financial relationships to disclose at this time.
Brian Biesman, M.D., FACS
has a financial relationship (Consultant) with Acclaro;.
has a financial relationship (Consultant) with Abbvie;.
has a financial relationship (Consultant) with Botanix;.
has a financial relationship (Consultant) with Canfield;.
has a financial relationship (Consultant) with Galderma;.
has a financial relationship (Consultant) with Hugel;.
has a financial relationship (Consultant) with La Mer;.
has a financial relationship (Consultant) with LOreal;.
has a financial relationship (Consultant) with LRM;.
has a financial relationship (Consultant) with Merz;.
has a financial relationship (Consultant) with Revance;.
has a financial relationship (Consultant) with Obagi;.
has a financial relationship (Consultant) with Revision;.
has a financial relationship (Consultant) with Sofwave;.
has a financial relationship (Consultant) with Solta;.
has a financial relationship (Consultant) with Teoxane;.
has a financial relationship (Consultant) with Veradermics;.
has a financial relationship (Consultant) with xMedica;.
has a financial relationship (Consultant) with SkinCeuticals;.
has a financial relationship (Individual stocks and stock options) with Acclaro;.
has a financial relationship (Individual stocks and stock options) with Cytrellis;.
Erin Boh, MD PhD
has no relevant financial relationships to disclose at this time.
Mark Broussard, BS Microbiology/Immunology; MS Organic Chemistry; MBA
has no relevant financial relationships to disclose at this time.
Vivian Bucay, MD, FAAD
has a financial relationship (Advisor) with Senté ;.
has a financial relationship (Advisor) with PCA Skin/CP Skin Health;.
has a financial relationship (Speaker) with Avène/Pierre Fabre;.
has a financial relationship (Advisor) with AO2 Skin;.
has a financial relationship (Speaker) with Skinceuticals/L'Oréal;.
has a financial relationship (Advisor) with SkinBetter Science/L'Oréal;.
has a financial relationship (Consultant) with SkinMedica/AbbVie;.
has a financial relationship (Advisor) with Estee Lauder;.
has a financial relationship (Speaker) with Eucerin/Beiersdorf;.
Bobby Buka
has no relevant financial relationships to disclose at this time.
Kimberly Butterwick
has a financial relationship (Advisor) with Allergan;.
has a financial relationship (Advisor) with Merz;.
has a financial relationship (Advisor) with Evolus;.
has a financial relationship (Advisor) with Galderma;.
has a financial relationship (Advisor) with Revance;.
has a financial relationship (Advisor) with Neutrogena;.
has a financial relationship (Individual stocks and stock options) with Rapalogix;.
Suneel Chilukuri, Suneel Chilukuri, M.D., FAAD, FASDS, FASLMS
has a financial relationship (Speaker) with Advalight;.
has a financial relationship (Speaker) with Aerolase Lasers;.
has a financial relationship (Speaker) with Allergan Aesthetics;.
has a financial relationship (Speaker) with BTL ;.
has a financial relationship (Speaker) with Clarity Rx;.
has a financial relationship (Speaker) with Crown Aesthetics;.
has a financial relationship (Speaker) with Evolus;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Speaker) with InMode;.
has a financial relationship (Speaker) with Merz;.
has a financial relationship (Speaker) with Prollenium Aesthetics;.
has a financial relationship (Speaker) with PCA Skin;.
has a financial relationship (Speaker) with Revance;.
has a financial relationship (Speaker) with Scientis;.
has a financial relationship (Speaker) with Sciton;.
has a financial relationship (Speaker) with Sente;.
has a financial relationship (Speaker) with Skin Medica;.
Lesley Clark-Loeser, MD, FAAD
has a financial relationship (Speaker) with Alastin/Galderma;.
has a financial relationship (Researcher) with Acclaro;.
has a financial relationship (Advisor) with AnteAge;.
has a financial relationship (Speaker) with Candela;.
has a financial relationship (Speaker) with BTL;.
has a financial relationship (Speaker) with Evolus;.
has a financial relationship (Advisor) with Neova;.
has a financial relationship (Speaker) with Prollenium;.
has a financial relationship (Advisor) with Revance;.
has a financial relationship (Speaker) with Scientis;.
has a financial relationship (Advisor) with SkinBetter;.
Joel Cohen, Board-Certified, American Board of Dermatology. Fellowship-Trained: Lasers / Aesthetics / Dermatologic Surgery
has a financial relationship (Consultant) with Galderma;.
has a financial relationship (Researcher) with Galderma;.
has a financial relationship (Consultant) with Revision;.
has a financial relationship (Consultant) with Acclaro;.
has a financial relationship (Consultant) with Cynosure-Lutronic;.
has a financial relationship (Consultant) with Revance;.
has a financial relationship (Consultant) with Allergan;.
has a financial relationship (Consultant) with Nutrafol;.
has a financial relationship (Researcher) with Allergan;.
has a financial relationship (Researcher) with BioFrontera;.
has a financial relationship (Researcher) with Veradermics;.
has a financial relationship (Researcher) with Castle ;.
Adriana Cruz, MD
has no relevant financial relationships to disclose at this time.
Carl D'Ruiz, MPH
has no relevant financial relationships to disclose at this time.
Steven Daveluy, MD
has a financial relationship (Advisor) with Abbvie, UCB, Novartis, Incyte;.
has a financial relationship (Speaker) with Abbvie, UCB, Novartis, Leo, Incyte;.
has a financial relationship (Researcher) with Abbvie, Novartis, UCB, Incyte, Insmed, Sanofi, Regeneron, Pfizer, Moonlake, Takeda;.
Zoe Draelos
has no relevant financial relationships to disclose at this time.
Scott drew, G. Scott Drew, DO, FAAD, FAOCD
has a financial relationship (Consultant) with abbvie;.
has a financial relationship (Consultant) with Lilly;.
has a financial relationship (Consultant) with galderma;.
has a financial relationship (Consultant) with Leo;.
has a financial relationship (Consultant) with Sun;.
has a financial relationship (Consultant) with arcutis;.
has a financial relationship (Consultant) with ucb;.
Nada Elbuluk, USC Keck School of Medicine Professor of Clinical Dermatology
has a financial relationship (Advisor) with AbbVie;.
has a financial relationship (Consultant) with AbbVie;.
has a financial relationship (Advisor) with Beiersdorf;.
has a financial relationship (Consultant) with Beiersdorf;.
has a financial relationship (Consultant) with Canfield Scientific;.
has a financial relationship (Advisor) with Dior;.
has a financial relationship (Advisor) with Eli Lilly;.
has a financial relationship (Researcher) with Eli Lilly;.
has a financial relationship (Advisor) with Incyte;.
has a financial relationship (Consultant) with Incyte;.
has a financial relationship (Advisor) with Janssen Biotech;.
has a financial relationship (Consultant) with Janssen Biotech;.
has a financial relationship (Consultant) with Kao USA;.
has a financial relationship (Advisor) with Kenvue;.
has a financial relationship (Advisor) with L'Oreal;.
has a financial relationship (Advisor) with McGraw Hill;.
has a financial relationship (Royalties or patent beneficiary) with McGraw Hill;.
has a financial relationship (Advisor) with Pfizer;.
has a financial relationship (Researcher) with Pfizer;.
has a financial relationship (Advisor) with Sanofi;.
has a financial relationship (Consultant) with Skinceuticals;.
has a financial relationship (Consultant) with Teva;.
has a financial relationship (Advisor) with Takeda;.
has a financial relationship (Consultant) with Veradermics;.
has a financial relationship (Individual stocks and stock options) with Visual DX;.
Patricia Farris
has a financial relationship (Advisor) with Nutraceutical Wellness ;.
has a financial relationship (Advisor) with Kenvue ;.
has a financial relationship (Advisor) with Skinceuticals ;.
has a financial relationship (Advisor) with Skinbetter ;.
has a financial relationship (Advisor) with AlumierMD ;.
has a financial relationship (Advisor) with Bubble ;.
has a financial relationship (Advisor) with Vichy;.
has a financial relationship (Advisor) with RegimenMD ;.
has a financial relationship (Advisor) with Primus ;.
has a financial relationship (Advisor) with Galderma ;.
Dee Glaser
has no relevant financial relationships to disclose at this time.
Michael Gold, M.D.
has a financial relationship (Consultant) with Acclaro;.
has a financial relationship (Consultant) with Advalight;.
has a financial relationship (Consultant) with Aerolase;.
has a financial relationship (Consultant) with Aesthetic Management Partners;.
has a financial relationship (Consultant) with Alastin/Galderma;.
has a financial relationship (Consultant) with Allergan Aesthetics/AbbVie;.
has a financial relationship (Consultant) with Alma Lasers;.
has a financial relationship (Consultant) with Bausch Health/Solta;.
has a financial relationship (Researcher) with Bausch Health/Solta;.
has a financial relationship (Consultant) with Benev;.
has a financial relationship (Consultant) with Croma;.
has a financial relationship (Researcher) with Benev;.
has a financial relationship (Researcher) with Croma;.
has a financial relationship (Consultant) with Cutera;.
has a financial relationship (Consultant) with EndyMed;.
has a financial relationship (Consultant) with ExocoBio;.
has a financial relationship (Consultant) with Hugel;.
has a financial relationship (Researcher) with Hugel;.
has a financial relationship (Consultant) with IBSA;.
has a financial relationship (Researcher) with IBSA;.
has a financial relationship (Consultant) with InMode;.
has a financial relationship (Consultant) with La Mer;.
has a financial relationship (Consultant) with Leo Pharma;.
has a financial relationship (Consultant) with Lumenis;.
has a financial relationship (Researcher) with Leo Pharma;.
has a financial relationship (Researcher) with Lumenis;.
has a financial relationship (Consultant) with Merz;.
has a financial relationship (Researcher) with Merz;.
has a financial relationship (Consultant) with MTF;.
has a financial relationship (Researcher) with MTF;.
has a financial relationship (Researcher) with Nordberg Medical;.
has a financial relationship (Consultant) with Nutrafol;.
has a financial relationship (Consultant) with Pierre Fabre/Glytone;.
has a financial relationship (Consultant) with Prescriber's Choice;.
has a financial relationship (Consultant) with Revance/Crown;.
has a financial relationship (Researcher) with Revance/Crown;.
has a financial relationship (Consultant) with Revision Skin Care;.
has a financial relationship (Researcher) with Revision Skin Care;.
has a financial relationship (Consultant) with Sciton;.
has a financial relationship (Consultant) with Sensus Healthcare;.
has a financial relationship (Consultant) with Skinbetter Science;.
has a financial relationship (Researcher) with Skinbetter Science;.
has a financial relationship (Consultant) with SkinCeuticals;.
has a financial relationship (Consultant) with Skin Medica;.
has a financial relationship (Consultant) with Sofwave;.
has a financial relationship (Researcher) with Sofwave;.
has a financial relationship (Consultant) with Stratpharma;.
has a financial relationship (Researcher) with Stratpharma;.
has a financial relationship (Consultant) with Strata Skin Sciences;.
has a financial relationship (Consultant) with Venus Concept;.
has a financial relationship (Researcher) with Venus Concept;.
has a financial relationship (Consultant) with VIOL;.
has a financial relationship (Consultant) with Vydence;.
David Goldberg
has a financial relationship (Independent contractor (including contracted research)) with Sofwave;.
has a financial relationship (Independent contractor (including contracted research)) with Absci;.
has a financial relationship (Independent contractor (including contracted research)) with AMP;.
Pearl Grimes
has no relevant financial relationships to disclose at this time.
Emma Guttman, MD, PhD
has a financial relationship (Researcher) with Regeneron, Sanofi, Eli Lilly, Pfizer, Amgen, GSK, Sanofi, Bristol Meyers Squibb, AnaptysBio, Abbvie, Opsidio, Apollo Therapeutics, Aclaris Therapeutics, Concerto Biosciences, Apogee, Enveda Biosciences, Nektar, Triveni Bio, Sitryx, Concert Pharmaceuticals;.
has a financial relationship (Consultant) with Abbvie, Aclaris Therapeutics, Almirall, Amgen, AnaptysBio, Apogee Therapeutics, Apollo Therapeutics, Arcutis, Artax Biopharma, Astria, Bambusa, Biolojic Design, Bionyra Pharma, Boerhinger-Ingelhiem, Bristol Meyers Squibb, Canyon Therapeutics, Celldex, Cue;.
Helen He
has a financial relationship (Speaker) with AbbVie;.
has a financial relationship (Researcher) with Clinique;.
Abid Husain, MD FACC ABAARM
has a financial relationship (Advisor) with NuBioAge;.
Rishabh Kala
has no relevant financial relationships to disclose at this time.
Mark Kaufmann
has a financial relationship (Consultant) with Almirall;.
has a financial relationship (Consultant) with Apogee;.
has a financial relationship (Consultant) with Biofrontera;.
has a financial relationship (Consultant) with Botanix;.
has a financial relationship (Consultant) with Dermtech;.
has a financial relationship (Consultant) with Feldan;.
has a financial relationship (Consultant) with Incyte;.
has a financial relationship (Consultant) with Modernizing Medicine;.
has a financial relationship (Consultant) with Novartis;.
has a financial relationship (Consultant) with Nuvidia;.
has a financial relationship (Consultant) with Oruka;.
has a financial relationship (Consultant) with Pelthos;.
has a financial relationship (Consultant) with Regeneron;.
has a financial relationship (Consultant) with Sun Pharma;.
has a financial relationship (Consultant) with UCB ;.
has a financial relationship (Consultant) with Veradermics;.
Edward Lain, MD
has a financial relationship (Advisor) with Galderma;.
has a financial relationship (Consultant) with Galderma;.
Ivy Lee
has no relevant financial relationships to disclose at this time.
Peter Lio, MD
has a financial relationship (Speaker) with Abbvie;.
has a financial relationship (Speaker) with Arcutis;.
has a financial relationship (Speaker) with Eli Lilly;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Speaker) with Incyte;.
has a financial relationship (Speaker) with L'Oreal;.
has a financial relationship (Speaker) with Pfizer;.
has a financial relationship (Speaker) with Pierre Fabre;.
has a financial relationship (Speaker) with Sanofi;.
has a financial relationship (Speaker) with Regeneron;.
has a financial relationship (Advisor) with Apogee;.
has a financial relationship (Advisor) with Astria Therapeutics;.
has a financial relationship (Advisor) with Castle Biosciences;.
has a financial relationship (Advisor) with Dermavant;.
has a financial relationship (Advisor) with Kenvue;.
has a financial relationship (Speaker) with LEO Pharma;.
has a financial relationship (Advisor) with Nektar Therapeutics;.
has a financial relationship (Advisor) with Phyla;.
has a financial relationship (Advisor) with Skinfix;.
has a financial relationship (Advisor) with Unilever;.
has a financial relationship (Individual stocks and stock options) with Alphyn Labs;.
has a financial relationship (Individual stocks and stock options) with Codex Labs;.
has a financial relationship (Individual stocks and stock options) with Concerto Biosci;.
has a financial relationship (Individual stocks and stock options) with Thimble Health;.
has a financial relationship (Individual stocks and stock options) with Topaz Bio;.
has a financial relationship (Individual stocks and stock options) with Yobee Care;.
has a financial relationship (Royalties or patent beneficiary) with Theraplex;.
Mary Lupo
has no relevant financial relationships to disclose at this time.
Chesahna MD, MBA, FAAD
has no relevant financial relationships to disclose at this time.
Rahul Mehta, PhD
has no relevant financial relationships to disclose at this time.
Richard Miller, MD, PhD
has a financial relationship (Advisor) with AstraZeneca;.
Amanda Mixon, PA-C
has no relevant financial relationships to disclose at this time.
Andrea Murina, MD
has a financial relationship (Speaker) with Abbvie;.
has a financial relationship (Speaker) with Amgen;.
has a financial relationship (Speaker) with Bristol Meyers Squibb;.
has a financial relationship (Speaker) with Botanix;.
has a financial relationship (Advisor) with Eli Lilly and Company;.
has a financial relationship (Speaker) with Novartis;.
has a financial relationship (Speaker) with Johnson and Johnson;.
has a financial relationship (Consultant) with Takeda;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Advisor) with Leo;.
has a financial relationship (Speaker) with Pfizer;.
has a financial relationship (Speaker) with UCB;.
Mark Nestor, MD, PhD
has a financial relationship (Consultant) with Aerolase;.
has a financial relationship (Advisor) with AMP Biologics;.
has a financial relationship (Consultant) with AMP Biologics;.
has a financial relationship (Advisor) with Absci;.
has a financial relationship (Consultant) with Beiersdorf;.
has a financial relationship (Consultant) with Benev Co. Inc.;.
has a financial relationship (Consultant) with Biofrontera;.
has a financial relationship (Researcher) with Biofrontera;.
has a financial relationship (Advisor) with Botanix;.
has a financial relationship (Researcher) with CROMA Pharma GmbH;.
has a financial relationship (Advisor) with Crown Aesthetics;.
has a financial relationship (Consultant) with Crown Aesthetics;.
has a financial relationship (Consultant) with Dermasensor;.
has a financial relationship (Consultant) with Dermsquared;.
has a financial relationship (Individual stocks and stock options) with Dermsquared;.
has a financial relationship (Advisor) with Eirion Therapeutics, Inc.;.
has a financial relationship (Consultant) with Eirion Therapeutics, Inc.;.
has a financial relationship (Researcher) with Eirion Therapeutics, Inc.;.
has a financial relationship (Consultant) with Emblation / Saorsa;.
has a financial relationship (Advisor) with Estee Lauder;.
has a financial relationship (Advisor) with Esthederm;.
has a financial relationship (Advisor) with Ferndale;.
has a financial relationship (Researcher) with Fudan-Zhangjiang, Co., Ltd;.
has a financial relationship (Advisor) with Galderma;.
has a financial relationship (Researcher) with Galderma;.
has a financial relationship (Advisor) with HTL Research;.
has a financial relationship (Consultant) with HTL Research;.
has a financial relationship (Advisor) with Hugel America;.
has a financial relationship (Advisor) with Ipsen;.
has a financial relationship (Consultant) with Ipsen;.
has a financial relationship (Researcher) with Ipsen;.
has a financial relationship (Researcher) with Jetema Co.;.
has a financial relationship (Researcher) with Krystal Biotech;.
has a financial relationship (Researcher) with Merz Pharma;.
has a financial relationship (Researcher) with Mino Labs;.
has a financial relationship (Advisor) with Novaestiq Corp;.
has a financial relationship (Consultant) with Novaestiq Corp;.
has a financial relationship (Advisor) with NuVida;.
has a financial relationship (Consultant) with NuVida;.
has a financial relationship (Advisor) with Obaji;.
has a financial relationship (Advisor) with One Skin;.
has a financial relationship (Advisor) with Primus Pharmaceuticals;.
has a financial relationship (Consultant) with Primus Pharmaceuticals;.
has a financial relationship (Advisor) with Regeneron;.
has a financial relationship (Advisor) with Revance / Crown;.
has a financial relationship (Consultant) with Revance / Crown;.
has a financial relationship (Consultant) with Revian;.
has a financial relationship (Researcher) with Revian;.
has a financial relationship (Advisor) with Sensus Healthcare;.
has a financial relationship (Consultant) with Sensus Healthcare;.
has a financial relationship (Speaker) with Sensus Healthcare;.
has a financial relationship (Advisor) with Sirnaomics;.
has a financial relationship (Consultant) with Sirnaomics;.
has a financial relationship (Researcher) with Sirnaomics;.
has a financial relationship (Consultant) with Sofwave;.
has a financial relationship (Individual stocks and stock options) with Strathspey Crown;.
has a financial relationship (Researcher) with Sun Pharma;.
has a financial relationship (Advisor) with Tiger Aesthetics;.
has a financial relationship (Consultant) with Tiger Aesthetics;.
has a financial relationship (Advisor) with Veradermics;.
has a financial relationship (Researcher) with Veradermics;.
has a financial relationship (Consultant) with Vial;.
has a financial relationship (Individual stocks and stock options) with Vial;.
has a financial relationship (Researcher) with Xtresse;.
Clifford Perlis, MD, MBioethics
has no relevant financial relationships to disclose at this time.
Jason Reichenberg, MD, MBA
has no relevant financial relationships to disclose at this time.
Todd Schlesinger, MD, FAAD
has a financial relationship (Advisor) with Avant Health, Chronicle Medical Software, Derma-Gene, SkinCure Oncology;.
has a financial relationship (Consultant) with Almirall, Galderma, Regeneron, Abbvie, SUN, Feldan Therapeutics, RBC, Lilly, Janssen,Novartis, Pfizer, SkinCure Oncology, Verrica;.
has a financial relationship (Researcher) with Almirall, Galderma, Regeneron, Abbvie, Medicus, SUN;.
has a financial relationship (Speaker) with Almirall, Arcutis, Benev, Galderma, Regeneron, BMS, UCB. SUN, Lilly, Janssen;.
Sarah Serrao, MSN, APRN, FNP-C
has a financial relationship (Advisor) with UCB;.
has a financial relationship (Researcher) with Sanofi;.
has a financial relationship (Researcher) with AnaptysBio;.
has a financial relationship (Researcher) with Cara Therapeutics, Inc. ;.
has a financial relationship (Researcher) with ACELYRIN, Inc.;.
has a financial relationship (Researcher) with Dermavant Sciences, Inc.;.
has a financial relationship (Speaker) with Organon ;.
has a financial relationship (Researcher) with Sun Pharma;.
has a financial relationship (Advisor) with Sanofi/Regeneron ;.
has a financial relationship (Advisor) with Organon ;.
has a financial relationship (Advisor) with Johnson & Johnson;.
has a financial relationship (Advisor) with Incyte;.
has a financial relationship (Advisor) with Verrica ;.
has a financial relationship (Advisor) with Sun Pharma;.
has a financial relationship (Advisor) with Arcutis ;.
has a financial relationship (Researcher) with Bristol-Myers Squibb;.
has a financial relationship (Researcher) with Oruka Therapeutics;.
has a financial relationship (Researcher) with Incyte;.
has a financial relationship (Researcher) with Eli Lilly;.
has a financial relationship (Researcher) with Apogee;.
has a financial relationship (Researcher) with Arcutis;.
has a financial relationship (Researcher) with Alumis;.
has a financial relationship (Researcher) with AbbVie;.
has a financial relationship (Researcher) with Q32Bio, Inc.;.
has a financial relationship (Researcher) with Regeneron;.
has a financial relationship (Researcher) with Pfizer;.
Asha Shah
has a financial relationship (Employee) with Kenvue;.
Ava Shamban, MD
has a financial relationship (Consultant) with Abbvie;.
has a financial relationship (Researcher) with Allergan;.
has a financial relationship (Consultant) with BENEV;.
has a financial relationship (Consultant) with Botanix;.
has a financial relationship (Consultant) with BTL;.
has a financial relationship (Consultant) with Cerave;.
has a financial relationship (Consultant) with Lumisque;.
has a financial relationship (Speaker) with Cynosure;.
has a financial relationship (Speaker) with Daxxify;.
has a financial relationship (Consultant) with Everesse;.
has a financial relationship (Consultant) with Evolus;.
has a financial relationship (Researcher) with Evolus;.
has a financial relationship (Consultant) with Galderma;.
has a financial relationship (Consultant) with Hugel;.
has a financial relationship (Speaker) with Hydrinity;.
has a financial relationship (Researcher) with Ipsen;.
has a financial relationship (Researcher) with Jetema;.
has a financial relationship (Speaker) with LRM Aesthetics;.
has a financial relationship (Researcher) with MERZ;.
has a financial relationship (Speaker) with MTF Biologics;.
has a financial relationship (Consultant) with Primus Pharmaceuticals;.
has a financial relationship (Researcher) with Q-med Galderma affiliated;.
has a financial relationship (Consultant) with Revance;.
has a financial relationship (Consultant) with Sinclair;.
has a financial relationship (Speaker) with SkinBetter;.
has a financial relationship (Consultant) with Teoxane;.
has a financial relationship (Researcher) with Teoxane;.
has a financial relationship (Consultant) with Veradermics;.
has a financial relationship (Consultant) with Xtresse;.
Raja Sivamani, MD
has a financial relationship (Consultant) with Arbonne;.
has a financial relationship (Consultant) with Codex Labs;.
has a financial relationship (Consultant) with Burts Bees;.
has a financial relationship (Consultant) with Bristol Meyers Squibb;.
has a financial relationship (Consultant) with Blueprints Medicine;.
has a financial relationship (Consultant) with Incyte;.
has a financial relationship (Consultant) with Nutraceutical Wellness;.
has a financial relationship (Consultant) with Galderma;.
has a financial relationship (Consultant) with Amgen;.
has a financial relationship (Consultant) with Almiral;.
has a financial relationship (Consultant) with Trace Mineral ;.
has a financial relationship (Consultant) with Abbvie;.
has a financial relationship (Consultant) with Leo;.
has a financial relationship (Consultant) with UCB;.
has a financial relationship (Speaker) with Sun Pharmaceuticals ;.
has a financial relationship (Consultant) with Pfizer ;.
has a financial relationship (Consultant) with Regeneron Pharmaceuticals;.
has a financial relationship (Consultant) with Phothera;.
has a financial relationship (Consultant) with Arcutis;.
has a financial relationship (Speaker) with Lilly;.
has a financial relationship (Speaker) with Janssen;.
has a financial relationship (Speaker) with Regeneron Pharmaceuticals;.
has a financial relationship (Speaker) with Phothera;.
has a financial relationship (Speaker) with Pfizer;.
has a financial relationship (Speaker) with UCB;.
has a financial relationship (Speaker) with Leo;.
has a financial relationship (Speaker) with Almirall;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Speaker) with Incyte;.
has a financial relationship (Speaker) with Bristol Myers Squibb;.
has a financial relationship (Consultant) with Lily;.
has a financial relationship (Consultant) with Novartis;.
has a financial relationship (Consultant) with Janssen;.
has a financial relationship (Speaker) with Abbvie;.
Linda Stein Gold, MD
has a financial relationship (Advisor) with J&J;.
has a financial relationship (Advisor) with Takeda;.
has a financial relationship (Advisor) with Lilly;.
has a financial relationship (Advisor) with Organon;.
has a financial relationship (Advisor) with Alumis;.
has a financial relationship (Advisor) with Arcutis;.
has a financial relationship (Advisor) with Amgen;.
has a financial relationship (Advisor) with Abbvie;.
Ruth Tedaldi
has no relevant financial relationships to disclose at this time.
Elizabeth Yurth, MD, ABPMR, ABAARM, FAARM
has no relevant financial relationships to disclose at this time.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Science of Skin Summit. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 21 Interprofessional Continuing Education (IPCE) credit for learning and change.
Available Credit
- 21.00 AAPA Category 1 CME
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 21.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. - 21.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 21.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 21.00 ANCC Contact Hours
Credit being awarded: 21.00 ANCC contact hours
- 21.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 21.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.